Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Elvanse
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Elvanse 50mg capsules
0404000U0BCACAD
|
Elvanse | Lisdexamfetamine dimesylate | Central Nervous System | 21,997 |
|
Elvanse 30mg capsules
0404000U0BCAAAB
|
Elvanse | Lisdexamfetamine dimesylate | Central Nervous System | 17,747 |
|
Elvanse 70mg capsules
0404000U0BCABAF
|
Elvanse | Lisdexamfetamine dimesylate | Central Nervous System | 14,462 |
|
Elvanse 40mg capsules
0404000U0BCAEAC
|
Elvanse | Lisdexamfetamine dimesylate | Central Nervous System | 12,538 |
|
Elvanse 20mg capsules
0404000U0BCADAA
|
Elvanse | Lisdexamfetamine dimesylate | Central Nervous System | 10,374 |
|
Elvanse 60mg capsules
0404000U0BCAFAE
|
Elvanse | Lisdexamfetamine dimesylate | Central Nervous System | 7,941 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.